Report Detail
Global Injectable Deoxycholic Acid Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4684117 |
- 12 March, 2026 |
- Global |
- 102 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Injectable Deoxycholic Acid market size was valued at US$ 430 million in 2025 and is forecast to a readjusted size of US$ 1105 million by 2032 with a CAGR of 15.4% during review period.
Injectable deoxycholic acid is a synthetic form of a naturally occurring secondary bile acid found in the human body. Clinically defined as a non-surgical cytolytic agent or lipolytic injectable, it works by physically disrupting the cell membrane of adipocytes (fat cells)—a process known as adipocytolysis. Once the fat cell membrane is destroyed, the cellular debris is cleared through the body's natural metabolic pathways, effectively reducing localized subcutaneous fat deposits, such as submental (double chin) fat. In 2025, global sales of injectable deoxycholic acid will reach 720,000 vials, with an average selling price of US$580 per vial. The supply chain of injectable deoxycholic acid is composed of upstream raw material R&D, midstream formulation manufacturing, and downstream clinical application. The upstream focuses on the production of high-purity Active Pharmaceutical Ingredients (API), utilizing complex chemical synthesis or bio-extraction to provide deoxycholic acid powder that meets pharmacopeia or medical-grade standards. The midstream is the core of the chain, where manufacturers with pharmaceutical or medical device licenses formulate the raw materials into sterile injectables through processes like aseptic blending, micro-encapsulation, or compound formulation, followed by regulatory validation and branding. The downstream involves pharmaceutical distribution and medical aesthetic clinics, where professional practitioners perform precise injections to achieve physical fat cell dissolution and metabolic clearance for end-users.
This report is a detailed and comprehensive analysis for global Injectable Deoxycholic Acid market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Injectable Deoxycholic Acid market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Injectable Deoxycholic Acid market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Injectable Deoxycholic Acid market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Injectable Deoxycholic Acid market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Injectable Deoxycholic Acid
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Injectable Deoxycholic Acid market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie (Kybella), Dermax, ICE Pharma, DEXLEVO(Kabelline), LG Chem(Bellacholine), Espad Pharmed, Curia, Marllor Biomedical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Injectable Deoxycholic Acid market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pure Deoxycholic Acid
Compound Formulations
Market segment by Compliance Level
Pharmaceutical Grade
Medical Device Grade
Cosmetic Grade
Market segment by Application
Dermatology Clinics
Hospitals
Others
Major players covered
AbbVie (Kybella)
Dermax
ICE Pharma
DEXLEVO(Kabelline)
LG Chem(Bellacholine)
Espad Pharmed
Curia
Marllor Biomedical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Injectable Deoxycholic Acid product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Injectable Deoxycholic Acid, with price, sales quantity, revenue, and global market share of Injectable Deoxycholic Acid from 2021 to 2026.
Chapter 3, the Injectable Deoxycholic Acid competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Injectable Deoxycholic Acid breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Injectable Deoxycholic Acid market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Injectable Deoxycholic Acid.
Chapter 14 and 15, to describe Injectable Deoxycholic Acid sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Injectable Deoxycholic Acid Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Pure Deoxycholic Acid
- 1.3.3 Compound Formulations
- 1.4 Market Analysis by Compliance Level
- 1.4.1 Overview: Global Injectable Deoxycholic Acid Consumption Value by Compliance Level: 2021 Versus 2025 Versus 2032
- 1.4.2 Pharmaceutical Grade
- 1.4.3 Medical Device Grade
- 1.4.4 Cosmetic Grade
- 1.5 Market Analysis by Application
- 1.5.1 Overview: Global Injectable Deoxycholic Acid Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.5.2 Dermatology Clinics
- 1.5.3 Hospitals
- 1.5.4 Others
- 1.6 Global Injectable Deoxycholic Acid Market Size & Forecast
- 1.6.1 Global Injectable Deoxycholic Acid Consumption Value (2021 & 2025 & 2032)
- 1.6.2 Global Injectable Deoxycholic Acid Sales Quantity (2021-2032)
- 1.6.3 Global Injectable Deoxycholic Acid Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 AbbVie (Kybella)
- 2.1.1 AbbVie (Kybella) Details
- 2.1.2 AbbVie (Kybella) Major Business
- 2.1.3 AbbVie (Kybella) Injectable Deoxycholic Acid Product and Services
- 2.1.4 AbbVie (Kybella) Injectable Deoxycholic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 AbbVie (Kybella) Recent Developments/Updates
- 2.2 Dermax
- 2.2.1 Dermax Details
- 2.2.2 Dermax Major Business
- 2.2.3 Dermax Injectable Deoxycholic Acid Product and Services
- 2.2.4 Dermax Injectable Deoxycholic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Dermax Recent Developments/Updates
- 2.3 ICE Pharma
- 2.3.1 ICE Pharma Details
- 2.3.2 ICE Pharma Major Business
- 2.3.3 ICE Pharma Injectable Deoxycholic Acid Product and Services
- 2.3.4 ICE Pharma Injectable Deoxycholic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 ICE Pharma Recent Developments/Updates
- 2.4 DEXLEVO(Kabelline)
- 2.4.1 DEXLEVO(Kabelline) Details
- 2.4.2 DEXLEVO(Kabelline) Major Business
- 2.4.3 DEXLEVO(Kabelline) Injectable Deoxycholic Acid Product and Services
- 2.4.4 DEXLEVO(Kabelline) Injectable Deoxycholic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 DEXLEVO(Kabelline) Recent Developments/Updates
- 2.5 LG Chem(Bellacholine)
- 2.5.1 LG Chem(Bellacholine) Details
- 2.5.2 LG Chem(Bellacholine) Major Business
- 2.5.3 LG Chem(Bellacholine) Injectable Deoxycholic Acid Product and Services
- 2.5.4 LG Chem(Bellacholine) Injectable Deoxycholic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 LG Chem(Bellacholine) Recent Developments/Updates
- 2.6 Espad Pharmed
- 2.6.1 Espad Pharmed Details
- 2.6.2 Espad Pharmed Major Business
- 2.6.3 Espad Pharmed Injectable Deoxycholic Acid Product and Services
- 2.6.4 Espad Pharmed Injectable Deoxycholic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Espad Pharmed Recent Developments/Updates
- 2.7 Curia
- 2.7.1 Curia Details
- 2.7.2 Curia Major Business
- 2.7.3 Curia Injectable Deoxycholic Acid Product and Services
- 2.7.4 Curia Injectable Deoxycholic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Curia Recent Developments/Updates
- 2.8 Marllor Biomedical
- 2.8.1 Marllor Biomedical Details
- 2.8.2 Marllor Biomedical Major Business
- 2.8.3 Marllor Biomedical Injectable Deoxycholic Acid Product and Services
- 2.8.4 Marllor Biomedical Injectable Deoxycholic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Marllor Biomedical Recent Developments/Updates
3 Competitive Environment: Injectable Deoxycholic Acid by Manufacturer
- 3.1 Global Injectable Deoxycholic Acid Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Injectable Deoxycholic Acid Revenue by Manufacturer (2021-2026)
- 3.3 Global Injectable Deoxycholic Acid Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Injectable Deoxycholic Acid by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Injectable Deoxycholic Acid Manufacturer Market Share in 2025
- 3.4.3 Top 6 Injectable Deoxycholic Acid Manufacturer Market Share in 2025
- 3.5 Injectable Deoxycholic Acid Market: Overall Company Footprint Analysis
- 3.5.1 Injectable Deoxycholic Acid Market: Region Footprint
- 3.5.2 Injectable Deoxycholic Acid Market: Company Product Type Footprint
- 3.5.3 Injectable Deoxycholic Acid Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Injectable Deoxycholic Acid Market Size by Region
- 4.1.1 Global Injectable Deoxycholic Acid Sales Quantity by Region (2021-2032)
- 4.1.2 Global Injectable Deoxycholic Acid Consumption Value by Region (2021-2032)
- 4.1.3 Global Injectable Deoxycholic Acid Average Price by Region (2021-2032)
- 4.2 North America Injectable Deoxycholic Acid Consumption Value (2021-2032)
- 4.3 Europe Injectable Deoxycholic Acid Consumption Value (2021-2032)
- 4.4 Asia-Pacific Injectable Deoxycholic Acid Consumption Value (2021-2032)
- 4.5 South America Injectable Deoxycholic Acid Consumption Value (2021-2032)
- 4.6 Middle East & Africa Injectable Deoxycholic Acid Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Injectable Deoxycholic Acid Sales Quantity by Type (2021-2032)
- 5.2 Global Injectable Deoxycholic Acid Consumption Value by Type (2021-2032)
- 5.3 Global Injectable Deoxycholic Acid Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Injectable Deoxycholic Acid Sales Quantity by Application (2021-2032)
- 6.2 Global Injectable Deoxycholic Acid Consumption Value by Application (2021-2032)
- 6.3 Global Injectable Deoxycholic Acid Average Price by Application (2021-2032)
7 North America
- 7.1 North America Injectable Deoxycholic Acid Sales Quantity by Type (2021-2032)
- 7.2 North America Injectable Deoxycholic Acid Sales Quantity by Application (2021-2032)
- 7.3 North America Injectable Deoxycholic Acid Market Size by Country
- 7.3.1 North America Injectable Deoxycholic Acid Sales Quantity by Country (2021-2032)
- 7.3.2 North America Injectable Deoxycholic Acid Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Injectable Deoxycholic Acid Sales Quantity by Type (2021-2032)
- 8.2 Europe Injectable Deoxycholic Acid Sales Quantity by Application (2021-2032)
- 8.3 Europe Injectable Deoxycholic Acid Market Size by Country
- 8.3.1 Europe Injectable Deoxycholic Acid Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Injectable Deoxycholic Acid Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Injectable Deoxycholic Acid Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Injectable Deoxycholic Acid Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Injectable Deoxycholic Acid Market Size by Region
- 9.3.1 Asia-Pacific Injectable Deoxycholic Acid Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Injectable Deoxycholic Acid Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Injectable Deoxycholic Acid Sales Quantity by Type (2021-2032)
- 10.2 South America Injectable Deoxycholic Acid Sales Quantity by Application (2021-2032)
- 10.3 South America Injectable Deoxycholic Acid Market Size by Country
- 10.3.1 South America Injectable Deoxycholic Acid Sales Quantity by Country (2021-2032)
- 10.3.2 South America Injectable Deoxycholic Acid Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Injectable Deoxycholic Acid Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Injectable Deoxycholic Acid Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Injectable Deoxycholic Acid Market Size by Country
- 11.3.1 Middle East & Africa Injectable Deoxycholic Acid Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Injectable Deoxycholic Acid Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Injectable Deoxycholic Acid Market Drivers
- 12.2 Injectable Deoxycholic Acid Market Restraints
- 12.3 Injectable Deoxycholic Acid Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Injectable Deoxycholic Acid and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Injectable Deoxycholic Acid
- 13.3 Injectable Deoxycholic Acid Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Injectable Deoxycholic Acid Typical Distributors
- 14.3 Injectable Deoxycholic Acid Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Injectable Deoxycholic Acid. Industry analysis & Market Report on Injectable Deoxycholic Acid is a syndicated market report, published as Global Injectable Deoxycholic Acid Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Injectable Deoxycholic Acid market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
